Research & Literature

Quantitative evaluation of a pediatric rheumatology transition program.

Jensen PT, Karnes J, Jones K, et al.

Pediatric rheumatology online journal 2015; (13()):17 doi:10.1186/s12969-015-0013-0.

Long-Term Health-Related Quality of Life in German Patients with Juvenile Idiopathic Arthritis in Comparison to German General Population.

Barth S, Haas JP, Schlichtiger J, et al.

PloS one 2016; (11(4)):e0153267 doi:10.1371/journal.pone.0153267.

[Uveitis associated with juvenile idiopathic arthritis : Optimization of immunomodulatory therapy].

Heiligenhaus A, Tappeiner C, Walscheid K, Heinz C

Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft 2016; (113(5)):391-7 doi:10.1007/s00347-016-0262-4.

Joint hypermobility and oligoarticular juvenile idiopathic arthritis: What relationship?

Cecchin V, Sperotto F, Balzarin M, et al.

Journal of paediatrics and child health 2017; (53(4)):374-377 doi:10.1111/jpc.13450.

Adalimumab plus Methotrexate for Uveitis in Juvenile Idiopathic Arthritis.

Ramanan AV, Dick AD, Jones AP, et al.

The New England journal of medicine 2017; (376(17)):1637-1646 doi:10.1056/NEJMoa1614160.

When a patient suspected with juvenile idiopathic arthritis turns out to be diagnosed with an infectious disease - a review of Lyme arthritis in children.

Orczyk K, Świdrowska-Jaros J, Smolewska E

Pediatric rheumatology online journal 2017; (15(1)):35 doi:10.1186/s12969-017-0166-0.

Clinical characteristics of juvenile idiopathic arthritis in an area of central Italy: a population-based study.

Marzetti V, Breda L, Miulli E, et al.

Annali di igiene : medicina preventiva e di comunita 2017; (29(4)):281-292 doi:10.7416/ai.2017.2152.

Protocols on classification, monitoring and therapy in children's rheumatology (PRO-KIND): results of the working group Polyarticular juvenile idiopathic arthritis.

Horneff G, Klein A, Ganser G, et al.

Pediatric rheumatology online journal 2017; (15(1)):78 doi:10.1186/s12969-017-0206-9.

Consensus-based recommendations for the management of uveitis associated with juvenile idiopathic arthritis: the SHARE initiative.

Constantin T, Foeldvari I, Anton J, et al.

Annals of the rheumatic diseases 2018; (77(8)):1107-1117 doi:10.1136/annrheumdis-2018-213131.

Risk Factors and Biomarkers for the Occurrence of Uveitis in Juvenile Idiopathic Arthritis: Data From the Inception Cohort of Newly Diagnosed Patients With Juvenile Idiopathic Arthritis Study.

Tappeiner C, Klotsche J, Sengler C, et al.

Arthritis & rheumatology (Hoboken, N.J.) 2018; (70(10)):1685-1694 doi:10.1002/art.40544.

Time of Disease-Modifying Antirheumatic Drug Start in Juvenile Idiopathic Arthritis and the Likelihood of a Drug-Free Remission in Young Adulthood.

Minden K, Horneff G, Niewerth M, et al.

Arthritis care & research 2019; (71(4)):471-481 doi:10.1002/acr.23709.

Prospective Determination of the Incidence and Risk Factors of New-Onset Uveitis in Juvenile Idiopathic Arthritis: The Research in Arthritis in Canadian Children Emphasizing Outcomes Cohort.

Lee JJY, Duffy CM, Guzman J, et al.

Arthritis care & research 2019; (71(11)):1436-1443 doi:10.1002/acr.23783.

Update of the evidence based, interdisciplinary guideline for anti-inflammatory treatment of uveitis associated with juvenile idiopathic arthritis.

Heiligenhaus A, Minden K, Tappeiner C, et al.

Seminars in arthritis and rheumatism 2019; (49(1)):43-55 doi:10.1016/j.semarthrit.2018.11.004.

Autoantibodies in the Pathogenesis, Diagnosis, and Prognosis of Juvenile Idiopathic Arthritis.

Mahmud SA, Binstadt BA

Frontiers in immunology 2018; (9()):3168 doi:10.3389/fimmu.2018.03168.

Long-Term Outcomes in Juvenile Idiopathic Arthritis: Eighteen Years of Follow-Up in the Population-Based Nordic Juvenile Idiopathic Arthritis Cohort.

Glerup M, Rypdal V, Arnstad ED, et al.

Arthritis care & research 2020; (72(4)):507-516 doi:10.1002/acr.23853.

2019 American College of Rheumatology/Arthritis Foundation Guideline for the Screening, Monitoring, and Treatment of Juvenile Idiopathic Arthritis-Associated Uveitis.

Angeles-Han ST, Ringold S, Beukelman T, et al.

Arthritis & rheumatology (Hoboken, N.J.) 2019; (71(6)):864-877 doi:10.1002/art.40885.

2019 American College of Rheumatology/Arthritis Foundation Guideline for the Treatment of Juvenile Idiopathic Arthritis: Therapeutic Approaches for Non-Systemic Polyarthritis, Sacroiliitis, and Enthesitis.

Ringold S, Angeles-Han ST, Beukelman T, et al.

Arthritis & rheumatology (Hoboken, N.J.) 2019; (71(6)):846-863 doi:10.1002/art.40884.

Time Effect of Intra-articular Injection With Triamcinolone Hexacetonide and Its Correlations: A Case-Control Prospective 12-Month Study.

Rocha RH, Natour J, Dos Santos RM, Furtado RNV

American journal of physical medicine & rehabilitation 2019; (98(10)):872-878 doi:10.1097/PHM.0000000000001217.

Juvenile idiopathic arthritis-associated uveitis: a retrospective analysis from a centre of South Italy.

Castagna I, Roszkowska AM, Alessandrello F, et al.

International ophthalmology 2020; (40(2)):335-342 doi:10.1007/s10792-019-01184-8.

Frequency and Identification of Risk Factors of Uveitis in Juvenile Idiopathic Arthritis: A Long-term Follow-up Study in a Cohort of Italian Children.

Conti G, Chirico V, Porcaro F, et al.

Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases 2020; (26(7)):285-288 doi:10.1097/RHU.0000000000001104.

Juvenile idiopathic arthritis-associated uveitis.

Sen ES, Ramanan AV

Clinical immunology (Orlando, Fla.) 2020; (211()):108322 doi:10.1016/j.clim.2019.108322.

Long-term outcomes and disease course of children with juvenile idiopathic arthritis in the ReACCh-Out cohort: a two-centre experience.

Chhabra A, Robinson C, Houghton K, et al.

Rheumatology (Oxford, England) 2020; (59(12)):3727-3730 doi:10.1093/rheumatology/keaa118.

Children with oligoarticular juvenile idiopathic arthritis have skewed synovial monocyte polarization pattern with functional impairment-a distinct inflammatory pattern for oligoarticular juvenile arthritis.

Schmidt T, Berthold E, Arve-Butler S, et al.

Arthritis research & therapy 2020; (22(1)):186 doi:10.1186/s13075-020-02279-9.

Prediction of inactive disease and relapse in oligoarticular juvenile idiopathic arthritis.

Sezer M, Aydın F, Kurt T, et al.

Modern rheumatology 2021; (31(5)):1025-1030 doi:10.1080/14397595.2020.1836788.

Recent advances in the treatment of juvenile idiopathic arthritis-associated uveitis.

Chen JL, Abiri P, Tsui E

Therapeutic advances in ophthalmology 2021; (13()):2515841420984572 doi:10.1177/2515841420984572.

Outcome of children with oligoarticular juvenile idiopathic arthritis compared to polyarthritis on methotrexate- data of the German BIKER registry.

Raab A, Kallinich T, Huscher D, et al.

Pediatric rheumatology online journal 2021; (19(1)):41 doi:10.1186/s12969-021-00522-4.

Epidemiology of pediatric uveitis and associated systemic diseases.

Shin Y, Kang JM, Lee J, et al.

Pediatric rheumatology online journal 2021; (19(1)):48 doi:10.1186/s12969-021-00516-2.

Synovial fluid neutrophils in oligoarticular juvenile idiopathic arthritis have an altered phenotype and impaired effector functions.

Arve-Butler S, Schmidt T, Mossberg A, et al.

Arthritis research & therapy 2021; (23(1)):109 doi:10.1186/s13075-021-02483-1.

Fifteen-minute guide to managing oligoarticular juvenile idiopathic arthritis.

McKenna D, McLaughlin D, Campbell C, et al.

Archives of disease in childhood. Education and practice edition 2022; (107(3)):175-181 doi:10.1136/archdischild-2020-321088.

Improved Disease Course Associated With Early Initiation of Biologics in Polyarticular Juvenile Idiopathic Arthritis: Trajectory Analysis of a Childhood Arthritis and Rheumatology Research Alliance Consensus Treatment Plans Study.

Ong MS, Ringold S, Kimura Y, et al.

Arthritis & rheumatology (Hoboken, N.J.) 2021; (73(10)):1910-1920 doi:10.1002/art.41892.

Juvenile idiopathic arthritis in Jordan: single center experience.

Alzyoud RM, Alsuweiti MO, Almaaitah HQ, et al.

Pediatric rheumatology online journal 2021; (19(1)):90 doi:10.1186/s12969-021-00572-8.

Juvenile Idiopathic Arthritis-Associated Chronic Uveitis: Recent Therapeutic Approaches.

Quartier P

Journal of clinical medicine 2021; (10(13)) doi:10.3390/jcm10132934.

Long Term Experience in Patients With JIA-Associated Uveitis in a Large Referral Center.

Marelli L, Romano M, Pontikaki I, et al.

Frontiers in pediatrics 2021; (9()):682327 doi:10.3389/fped.2021.682327.

Early intra-articular corticosteroid injection is predictors of remission of juvenile idiopathic arthritis.

Filosco F, Giallongo A, Leonardi S, et al.

Minerva pediatrics 2023; (75(3)):400-409 doi:10.23736/S2724-5276.21.06343-6.

Definition and Validation of the American College of Rheumatology 2021 Juvenile Arthritis Disease Activity Score Cutoffs for Disease Activity States in Juvenile Idiopathic Arthritis.

Trincianti C, Van Dijkhuizen EHP, Alongi A, et al.

Arthritis & rheumatology (Hoboken, N.J.) 2021; (73(11)):1966-1975 doi:10.1002/art.41879.

Juvenile Idiopathic Arthritis Treatment Updates.

Onel K, Rumsey DG, Shenoi S

Rheumatic diseases clinics of North America 2021; (47(4)):545-563 doi:10.1016/j.rdc.2021.07.009.

Juvenile Fibromyalgia.

Weiss JE, Kashikar-Zuck S

Rheumatic diseases clinics of North America 2021; (47(4)):725-736 doi:10.1016/j.rdc.2021.07.002.

Health-related quality of life and disability in adults with juvenile idiopathic arthritis: comparison with adult-onset rheumatic diseases.

Oliveira Ramos F, Rodrigues A, Magalhaes Martins F, et al.

RMD open 2021; (7(3)) doi:10.1136/rmdopen-2021-001766.

Changing Patterns in Treatment, Remission Status, and Categories in a Long-Term Nordic Cohort Study of Juvenile Idiopathic Arthritis.

Glerup M, Arnstad ED, Rypdal V, et al.

Arthritis care & research 2022; (74(5)):719-727 doi:10.1002/acr.24857.

2021 American College of Rheumatology Guideline for the Treatment of Juvenile Idiopathic Arthritis: Therapeutic Approaches for Oligoarthritis, Temporomandibular Joint Arthritis, and Systemic Juvenile Idiopathic Arthritis.

Onel KB, Horton DB, Lovell DJ, et al.

Arthritis care & research 2022; (74(4)):521-537 doi:10.1002/acr.24853.

A Comparison of International League of Associations for Rheumatology and Pediatric Rheumatology International Trials Organization Classification Systems for Juvenile Idiopathic Arthritis Among Children in a Canadian Arthritis Cohort.

Lee JJY, Eng SWM, Guzman J, et al.

Arthritis & rheumatology (Hoboken, N.J.) 2022; (74(8)):1409-1419 doi:10.1002/art.42113.

Therapeutic strategies for treating juvenile idiopathic arthritis.

Mannion ML, Cron RQ

Current opinion in pharmacology 2022; (64()):102226 doi:10.1016/j.coph.2022.102226.

What are the factors associated with the duration of remission of intra-articular corticosteroid injection in juvenile idiopathic arthritis?

Aydın F, Çakar N, Kurt T, et al.

Clinical rheumatology 2022; (41(12)):3791-3796 doi:10.1007/s10067-022-06327-4.

Risk Factors for Ocular Complications and Visual Loss in Patients with Juvenile Idiopathic Arthritis-associated Uveitis at a Turkish Tertiary Ophthalmology and Pediatric Rheumatology Referral Center.

Kardes E, Sözeri B, Demir F, Sezgin Akcay BI

Ocular immunology and inflammation 2023; (31(10)):1984-1991 doi:10.1080/09273948.2022.2123833.

CCL24, CXCL9 and CXCL10 are increased in synovial fluid in patients with juvenile idiopathic arthritis requiring advanced treatment.

Al-Jaberi L, Simonds MM, Brescia AMC

Rheumatology (Oxford, England) 2023; (62(7)):2594-2600 doi:10.1093/rheumatology/keac617.

The Importance of Differentiating Oligoarticular Juvenile Idiopathic Arthritis From Lyme Arthritis in Pediatric Patients.

Jeelani W, Harhay R, Wrotniak BH, et al.

Cureus 2022; (14(12)):e32785 doi:10.7759/cureus.32785.

Subtype frequency, demographic features, treatment and outcome of Juvenile Arthritis in one Centre in Abu Dhabi in the United Arab Emirates.

Khawaja K, Kalas R, Almasri N

Pediatric rheumatology online journal 2023; (21(1)):14 doi:10.1186/s12969-023-00796-w.

Serum Calprotectin Levels in Different Subtypes of Juvenile Idiopathic Arthritis (JIA) and Its Correlation with Quantitative CRP and JADAS-27.

Remthangpuii F, Maheshwari A, Gulati S, et al.

Indian journal of pediatrics 2023; (90(12)):1177-1181 doi:10.1007/s12098-022-04414-7.

The effects of inspiratory muscle training on cardiorespiratory functions in juvenile idiopathic arthritis: A randomized controlled trial.

Sarac DC, Bayraktar D, Ozer Kaya D, et al.

Pediatric pulmonology 2024; (59(3)):562-573 doi:10.1002/ppul.26783.

Assessment of quality of life and physical activity in patients with oligoarticular juvenile idiopathic arthritis in remission.

Polat MC, Çelikel E, Tekin ZE, et al.

European journal of pediatrics 2024; (183(2)):955-964 doi:10.1007/s00431-023-05367-5.

Treatment of non-systemic juvenile idiopathic arthritis.

Shenoi S, Horneff G, Aggarwal A, Ravelli A

Nature reviews. Rheumatology 2024; (20(3)):170-181 doi:10.1038/s41584-024-01079-8.

Evaluation of medication withdrawal in patients with non-systemic juvenile idiopathic arthritis in Japan using a web-based survey.

Ebato T, Kishi T, Akamine K, et al.

Modern rheumatology 2024; (34(6)):1231-1237 doi:10.1093/mr/roae016.

When should the use of biological agents be considered in persistent oligoarticular juvenile idiopathic arthritis patients?

Polat MC, Çelikel E, Tekin ZE, et al.

European journal of pediatrics 2024; (183(6)):2725-2731 doi:10.1007/s00431-024-05538-y.

Factors determining resistance to conventional disease-modifying anti-rheumatic drug treatment in oligoarticular juvenile idiopathic arthritis.

Sener S, Aliyev E, Batu ED, et al.

Clinical rheumatology 2024; (43(6)):2021-2026 doi:10.1007/s10067-024-06925-4.

Uveitis Profile in Children and Its Impact on Vision at Queen Rania Children's Hospital.

Otoum MM, Al Adwan NM, Haddad HK, et al.

Cureus 2024; (16(4)):e59136 doi:10.7759/cureus.59136.

Ultrasonographic evaluation of changes in the joint before and after intra-articular injection in children with juvenile idiopathic arthritis.

Turkmen S, Sozeri B

Northern clinics of Istanbul 2024; (11(3)):241-248 doi:10.14744/nci.2024.55481.

Functional status of Indian children with juvenile idiopathic arthritis.

Datta D, Khatun M, Bankura B, et al.

Rheumatology and immunology research 2024; (5(2)):126-129 doi:10.1515/rir-2024-0016.

Magnetic resonance imaging of the musculoskeletal system in the diagnosis of rheumatic diseases in the pediatric population.

Ożga J, Mężyk E, Kmiecik W, et al.

Reumatologia 2024; (62(3)):196-206 doi:10.5114/reum/190262.

Pediatric Uveitis in a Tertiary Referral Center in East China: Clinical Patterns and Visual Outcomes.

Lei B, Zhou X, Gu R, et al.

Journal of ophthalmology 2024; (2024()):5015614 doi:10.1155/joph/5015614.

Diagnostic challenges in pediatric arthritis: A case of systemic juvenile idiopathic arthritis misdiagnosed as septic arthritis in a 3-year-old boy.

Alesaeidi S, Jari M

SAGE open medical case reports 2024; (12()):2050313X241305166 doi:10.1177/2050313X241305166.

The impact of BMI on disease activity and growth outcomes in juvenile idiopathic arthritis.

Yıldız Ç, Küçükali B, Kutlar M, et al.

European journal of pediatrics 2025; (184(4)):259 doi:10.1007/s00431-025-06084-x.

The long-term follow up of patients with oligoarticular juvenile idiopathic arthritis: a single center experience.

Aliyeva A, Adrovic A, Aslak F, et al.

Medicinski glasnik : official publication of the Medical Association of Zenica-Doboj Canton, Bosnia and Herzegovina 2025; (22(2)):299-303 doi:10.17392/1905-22-02.

Novel Immune biomarkers for the early stratification of oligoarthritis patients at risk of developing polyarticular extension.

Raggi F, Pelassa S, Antonini F, et al.

Frontiers in immunology 2025; (16()):1663663 doi:10.3389/fimmu.2025.1663663.

Biologic therapy through caregivers' eyes: insights from a multicenter pediatric rheumatology survey.

Başer Taşkın B, Doğru Kılınç A, Karadoğan MT, et al.

Expert opinion on biological therapy 2025; (25(11)):1257-1264 doi:10.1080/14712598.2025.2597849.

A Canadian Advanced Physiotherapist Practitioner Shared-Care Model in Pediatric Rheumatology Offers Safe and Quality Care in the Management of Juvenile Idiopathic Arthritis-Comparing Key Performance Indicators with the PR-COIN Registry.

Herrington J, Clarkin P, Singleton J, et al.

Children (Basel, Switzerland) 2025; (12(12)) doi:10.3390/children12121675.

PAFLAR guidelines for oligoarticular juvenile idiopathic arthritis.

Hassan W, Mosa DM, Faleye A, et al.

Clinical rheumatology 2026; (45(2)):1323-1336 doi:10.1007/s10067-025-07792-3.

Pan American League of Associations for Rheumatology: Recommendations for the Treatment of Oligoarticular Juvenile Idiopathic Arthritis.

Morel Z, Espada G, Eraso R, et al.

Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases 2026; (32(2)):e55-e65 doi:10.1097/RHU.0000000000002316.